Private Equity

Industry veteran Wes Champion takes the helm at VMG Health, signaling a new era of aggressive, PE-backed expansion in the complex healthcare consulting market.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.

Cizzle Brands' $83.75M acquisition of Flow Water's manufacturing arm is a strategic masterstroke, creating a vertically integrated beverage powerhouse.

Collegium Pharmaceutical projects robust 2026 revenue fueled by its ADHD drug Jornay PM, savvy debt refinancing, and a proactive generic strategy.

Keystone doubles down on AI advisory with Audax Private Equity's backing, spinning off its supply chain software unit into a new powerhouse, Keystone AI.

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

The medtech firm's preliminary results show a Q4 revenue uptick but miss yearly estimates, signaling a stabilizing but cautious path forward for 2026.

The special mission aviation provider completes a buyout of Bain Capital, consolidating NTC Group's ownership and securing new capital to expand its services.

With a 432% share price jump and billions in financing lined up, Troilus Gold's Quebec project is becoming a cornerstone of North America's critical minerals.

Calgary-based Horizon Petroleum faces a Management Cease Trade Order over delayed financial filings, raising questions about its European operations.

With major backing from Goldman Sachs, a biotech firm is advancing a potentially life-changing gene therapy for a rare, progressive form of blindness.

Luxury brand owner Tapestry partners with Pivot Energy on Illinois solar projects, powering homes and funding new green job training programs for locals.

With over 30 years of experience, Leonard Carder takes the helm at 4M Building Solutions, signaling a new chapter of aggressive acquisition and innovation.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

The acquisition, advised by Westcove Partners, highlights the trend of private equity-fueled consolidation aimed at enhancing clinical trial access.

SNDL finalizes the first phase of a major retail acquisition from 1CM, signaling deeper market consolidation and a strategic push into Ontario's market.

With a C$20M financing deal, Generation Mining is pushing its 'shovel-ready' Marathon copper-palladium project closer to construction.

Garnering top ESG ratings, multiple Newsweek awards, and its first LEED certification, Park Hotels proves sustainability is a core business strategy.

An updated study confirms a 70-year mine life and $2B value for Karnalyte's Wynyard potash project, but the multi-billion dollar financing remains key.